We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0QDU market cap is 2.8B. The company's latest EPS is SEK -0.0904 and P/E is -29.31.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 3.63M | 1.76M | 151k | 31k | 137k |
| Operating Income | -76.63M | -60.17M | -123.15M | -84.91M | -97.86M |
| Net Income | -76.99M | -59.99M | -123.49M | -85.26M | -95.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 148.49M | 150.66M | 58.92M | 183.83M | 87.5M |
| Total Liabilities | 20.7M | 10.3M | 17.39M | 19.54M | 16.78M |
| Total Equity | 127.8M | 140.36M | 41.53M | 164.29M | 70.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | -72.41M | -67.56M | -114.08M | -159.56M | -7.8M |
| Investing | -2.7M | -1.41M | -1.09M | -905k | -1.29M |
| Financing | 107.47M | 72.3M | 75.79M | 204.42M | 415k |
| Market Cap | 2.8B |
| Price to Earnings Ratio | -29.31 |
| Price to Sales Ratio | 26.5k |
| Price to Cash Ratio | 48.53 |
| Price to Book Ratio | 39.58 |
| Dividend Yield | - |
| Shares Outstanding | 1.06B |
| Average Volume (1 week) | 19.28k |
| Average Volume (1 Month) | 9.66k |
| 52 Week Change | 0.00% |
| 52 Week High | 2.65 |
| 52 Week Low | 2.65 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Abliva Ab |
| Address |
medicon village lund 223 81 |
| Website | https://www.abliva.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
